Compare Nokia Corp (NOK) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs ResMed Inc. — how do they compare? Nokia Corp trades at $11.12 (market cap $56.35B), while ResMed Inc. trades at $222 (market cap $32.94B). The key difference: Nokia Corp is the larger of the two by market cap, and Nokia Corp pays the higher dividend (1.63%). Which is the better fit depends on your goals.
| NOK | RMD | |
|---|---|---|
Market Cap | $56.35B | $32.94B |
Sector | Technology | Health |
52-Week High | $16.83 | $283.28 |
52-Week Low | $4.51 | $182.82 |
Enterprise Value | $54.29B | $32.30B |
Dividend Yield | 1.63% | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nokia (NOK) trades at $10.66, up 6.18% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.08, beating expectations, while revenue trends show stabilization around $20B annually. Recent news highlights AI network expansion and Euro Stoxx 50 inclusion, though cash flow turned negative in 2025.
Nokia presents a balanced risk-reward profile with strong analyst support (62% buy ratings) but faces execution risks in AI growth initiatives. The stock's elevated P/E ratio of 72.15 requires sustained earnings acceleration to justify valuation, while competitive pressures in telecom infrastructure remain a key challenge for margin expansion.
ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support. The company reported strong Q4 2026 earnings, beating estimates with $2.95 EPS and 9% revenue growth to $1.5 billion, while announcing a $0.66 dividend. Fundamentals remain robust with a 26.94% net income margin and 24.27% ROE, though a weak 2027 sales forecast has tempered sentiment.
The outlook is mixed; solid profitability and consistent earnings beats support upside toward the $235.70 consensus target, but investor caution persists due to the bearish technical trend and revenue guidance concerns. Key risks include competitive pressures and macroeconomic headwinds impacting medical device demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
